Free Trial

Picton Mahoney Asset Management Buys 21,328 Shares of Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Key Points

  • Picton Mahoney Asset Management increased its position in Maximus, Inc. by 164,061.5%, acquiring 21,328 shares in the first quarter, bringing their total holdings to 21,341 shares valued at $1.46 million.
  • Maximus reported an earnings per share of $2.01 for the most recent quarter, significantly beating analysts' expectations of $1.37, with revenues reaching $1.36 billion.
  • The company recently announced a $0.30 quarterly dividend, with a yield of 1.67%, payable on August 31st to investors of record as of August 15th.
  • Five stocks we like better than Maximus.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Picton Mahoney Asset Management grew its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 164,061.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,341 shares of the health services provider's stock after buying an additional 21,328 shares during the period. Picton Mahoney Asset Management's holdings in Maximus were worth $1,456,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the business. UMB Bank n.a. raised its holdings in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the last quarter. GAMMA Investing LLC raised its holdings in Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after buying an additional 294 shares during the last quarter. NBC Securities Inc. raised its holdings in Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after purchasing an additional 1,149 shares in the last quarter. Blue Trust Inc. raised its holdings in Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares in the last quarter. Finally, LRI Investments LLC raised its holdings in Maximus by 44.1% in the 4th quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock worth $122,000 after purchasing an additional 501 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Activity at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Read Our Latest Stock Report on MMS

Maximus Stock Performance

Shares of NYSE MMS traded down $0.51 during trading on Wednesday, reaching $71.25. 361,858 shares of the company traded hands, compared to its average volume of 394,607. The firm has a 50 day simple moving average of $71.30 and a 200-day simple moving average of $70.61. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $4.01 billion, a PE ratio of 14.17 and a beta of 0.61. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The firm had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter in the prior year, the business earned $1.57 EPS. The business's quarterly revenue was up 1.0% on a year-over-year basis. Equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.68%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio (DPR) is presently 23.86%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines